EGFR (del746-750, T790M, C797S), GST-Tag, His-Tag Recombinant

Catalog #
100187
$540 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human EGFR (epidermal growth factor receptor) encompassing tyrosine kinase domain amino acids 668-1210(end) with a deletion of amino acids 746 to 750 and mutations T790M and C797S. This construct contains an N-terminal GST-tag and a C-terminal His-tag (6xHis). This protein was affinity purified. 

Synonyms
Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
Product Info
Storage and Usage
Citations
Species
Human
Construct
EGFR (GST-668-1210(end)-His)
Mutation
del746-750, T790M, C797S
Host Species/Expression System
Sf9
Purity

≥65%

Format

Aqueous buffer solution.

Formulation

40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 0.04% Tween-20, 20% glycerol, and 3 mM DTT

MW
87 kDa
Amino Acids
668-1210(end)
Genbank #
NM_005228
UniProt #
P00533
Tag(s)
N-terminal GST-tag, C-terminal His-tag
Background

EFGR (epidermal growth factor receptor), also known as ErbB-1 and HER1, is the cell-surface receptor for members of the epidermal growth factor family, such as TGFα (transforming growth factor alpha) and belongs to the ErbB family of receptors. Overexpression and/or hyperactivation of EGFR is associated with several human cancers such as lung, glioblastoma, and epithelial tumors of the neck and head, whereas EGFR deficiency is linked to Alzheimer’s. After binding to its ligand, EGFR dimerizes and undergoes auto-phosphorylation, resulting in activation of signal transduction cascades that involve proteins such as JNK (c-jun N-terminal kinases) and AKT (protein kinase B). Its role as an oncogene has led to the development of inhibitors as cancer therapy.